Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.270
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.390
+0.120 (2.80%)
After-hours: Dec 5, 2025, 7:18 PM EST
Neuphoria Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Neuphoria Therapeutics stock have an average target of 21, with a low estimate of 7.00 and a high estimate of 35. The average target predicts an increase of 391.80% from the current stock price of 4.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neuphoria Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $7 | Strong Buy | Maintains | $21 → $7 | +63.93% | Dec 5, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $18 → $35 | Strong Buy | Maintains | $18 → $35 | +719.67% | Sep 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +391.80% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $21 | Strong Buy | Maintains | $8 → $21 | +391.80% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
n/a
from 15.65M
Revenue Next Year
n/a
EPS This Year
-4.84
from -0.23
EPS Next Year
-4.02
from -4.84
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.00 | -1.27 | |
| Avg | -4.84 | -4.02 | |
| Low | -6.93 | -5.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.